By validating its relationship in a cohort of human CRC and within an animal model, this study identifies c-Cbl as a modifier for CRC pathogenesis and a contributor to the heterogeneity in Wnt activity in human CRC. The gene discussed is CBL; the disease is colorectal carcinoma.